A case series of paediatric patients with spinal muscular atrophy type I undergoing scoliosis correction surgery

Loading next page...

Pan‐ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens

Sugarman, EA; Nagan, N; Zhu, H
Nusinersen versus sham control in infantile‐onset spinal muscular atrophy

Finkel, RS; Mercuri, E; Darras, BT
Anesthesia and spinal muscle atrophy

Islander, G
Anesthesia and perioperative medical management of children with spinal muscular atrophy

Graham, RJ; Athiraman, U; Laubach, AE; Sethna, NF
Spinal surgery in children with idiopathic and neuromuscular scoliosis. What’s the difference?

Murphy, NA; Firth, S; Jorgensen, T; Young, PC
Difficult airway in a child with spinal muscular atrophy type I

Arima, H; Sobue, K; Tanaka, S; Morishima, T; Ando, H; Katsuya, H
The impact of scoliosis surgery on pulmonary function in spinal muscular atrophy: a systematic review

Alhammoud, A; Othman, Y; El‐Hawary, R; Mackenzie, WG; Howard, JJ
Low bone mineral density in spinal muscular atrophy

Khatri, IA; Chaudhry, US; Seikaly, MG; Browne, RH; Iannaccone, ST
Nusinersen injections in adults and children with spinal muscular atrophy: a single‐center experience

Özütemiz, C; Karachunski, P; Nascene, DR
Onasemnogene abeparvovec gene therapy for symptomatic infantile‐onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open‐label, single‐arm, multicentre, phase 3 trial

Day, JW; Finkel, RS; Chiriboga, CA